Discounted Cash Flow (DCF) Analysis Unlevered

BioCardia, Inc. (BCDAW)

$0.24

0.00 (0.00%)
All numbers are in Millions, Currency in USD
Stock DCF: - | 0.24 | undervalue

Operating Data

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Revenue 0.480.620.710.141.012.455.9014.2334.3182.73
Revenue (%)
EBITDA -12.23-13.90-14.49-14.93-12.55-89.83-216.61-522.31-1,259.43-3,036.80
EBITDA (%)
EBIT -12.31-13.99-14.60-15-12.61-90.32-217.78-525.12-1,266.21-3,053.15
EBIT (%)
Depreciation 0.080.090.110.070.060.481.172.816.7816.35
Depreciation (%)

Balance Sheet Data

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash 12.695.365.5821.4112.8799.49239.89578.431,394.733,363.06
Total Cash (%)
Account Receivables 0.090.270.150.040.290.691.6649.6523.27
Account Receivables (%)
Inventories 0.190.1400.030.210.511.242.997.2117.37
Inventories (%)
Accounts Payable 0.901.020.910.750.515.1112.3329.7371.69172.86
Accounts Payable (%)
Capital Expenditure -0.14-0.07-0.15-0.03-0.12-0.46-1.10-2.65-6.38-15.39
Capital Expenditure (%)

Weighted Average Cost Of Capital

Share price $ 0.24
Beta 0.000
Diluted Shares Outstanding -
Cost of Debt
Tax Rate 0.00
After-tax Cost of Debt 0.48%
Risk-Free Rate
Market Risk Premium
Cost of Equity 2.859
Total Debt 1.87
Total Equity -
Total Capital -
Debt Weighting -
Equity Weighting -
Wacc

Build Up Free Cash

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Revenue 0.480.620.710.141.012.455.9014.2334.3182.73
EBITDA -12.23-13.90-14.49-14.93-12.55-89.83-216.61-522.31-1,259.43-3,036.80
EBIT -12.31-13.99-14.60-15-12.61-90.32-217.78-525.12-1,266.21-3,053.15
Tax Rate 0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIAT -12.31-13.99-14.60-15-12.61-90.32-217.78-525.12-1,266.21-3,053.15
Depreciation 0.080.090.110.070.060.481.172.816.7816.35
Accounts Receivable --0.180.130.11-0.24-0.40-0.97-2.34-5.65-13.62
Inventories -0.050.14-0.03-0.18-0.30-0.73-1.75-4.22-10.17
Accounts Payable -0.12-0.11-0.17-0.244.617.2217.4041.96101.17
Capital Expenditure -0.14-0.07-0.15-0.03-0.12-0.46-1.10-2.65-6.38-15.39
UFCF -12.37-13.98-14.47-15.05-13.34-86.39-212.19-511.65-1,233.72-2,974.81
WACC
PV UFCF -----
SUM PV UFCF -

Terminal Value

Growth in perpetuity method:
Long-term growth rate
WACC (%) -
Free cash flow (t + 1) -3,034.30
Terminal Value -
Present Value of Terminal Value -

Intrinsic Value

Enterprise Value -
Net Debt -11
Equity Value -
Shares Outstanding -
Equity Value Per Share -